Top Markets
#1 Glidr Glidr +51.75%
#2 Akedo Akedo +50.81%
#3 DOVU DOVU +50.51%
#4 Cross Cross +49.17%
#5 Black Phoenix Black Phoenix +34.33%
#6 Velvet Velvet +32.01%
#7 OVERTAKE OVERTAKE +22.01%
#8 Cap Cap +17.55%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +16.87%
#10 Movement Movement +13.76%
Coin of the day
Glidr Glidr
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Redx Pharma Plc Redx Pharma Plc

Redx Pharma Plc

REDX
Classifica tra le azioni #38811
Redx Pharma Plc, established in the United Kingdom in 2010 and headquartered in... Redx Pharma Plc, established in the United Kingdom in 2010 and headquartered in Macclesfield, concentrates its efforts on the discovery, early-stage preclinical development, and licensing of innovative small molecule drugs. The company primarily targets significant unmet medical needs in the therapeutic areas of oncology and fibrosis. Within its oncology portfolio, Redx is progressing RXC004, a porcupine inhibitor currently undergoing Phase II clinical evaluation for treating cancers driven by Wnt-ligands. Additionally, it maintains a research collaboration with Jazz Pharmaceuticals plc, aiming to identify and advance new drug candidates for two specific cancer pathways: the Ras/Raf/MAP kinase pathway. For fibrotic conditions, Redx Pharma is developing several compounds, including RXC007, an oral selective ROCK2 inhibitor intended for the treatment of various fibrotic diseases. Its pipeline also features a gastrointestinal-targeted ROCK inhibitor specifically designed to address fibrosis associated with Crohn's disease, along with a discoidin domain receptors (DDRs) inhibitor for a range of fibrotic disorders. Furthermore, the company is developing RXC006, another porcupine inhibitor, focused on combating fibrotic illnesses such as idiopathic pulmonary fibrosis.
Prezzo delle azioni
$0.20410523
Ultima sincronizzazione: 2024-04-30
Capitalizzazione di mercato
$793.94K
Variazione (1 giorno)
42.54%
Variazione (1 anno)
0.00%
Paese
GB
Scambia Redx Pharma Plc (REDX)

Categoria

Healthcare
Storico del prezzo dell'azione per Redx Pharma Plc (REDX)
Prezzo di chiusura più alto: $0.12 il 2024-04-01

Prezzo di chiusura più basso: $1.26 il 2015-03-01
Storico del prezzo dell'azione di Redx Pharma Plc dal 2015 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2024 -59.88%
2023 -59.57%
2022 -25.78%
2021 29.62%
2020 711.52%
2019 9.53%
2018 -70.73%
2017 -45.20%
2016 -51.74%
2015 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $506.92 29.88%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $843.33 29.26%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 7.13%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.25%
BE